DISOPYRAMIDE Drug Patent Profile
✉ Email this page to a colleague
When do Disopyramide patents expire, and when can generic versions of Disopyramide launch?
Disopyramide is a drug marketed by Nesher Pharms, Dr Reddys Labs Sa, Interpharm, Ivax Sub Teva Pharms, Mylan, Rising, Sun Pharm Industries, Superpharm, Teva, and Watson Labs. and is included in eighteen NDAs.
The generic ingredient in DISOPYRAMIDE is disopyramide phosphate. There are nineteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the disopyramide phosphate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Disopyramide
A generic version of DISOPYRAMIDE was approved as disopyramide phosphate by TEVA on February 22nd, 1985.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DISOPYRAMIDE?
- What are the global sales for DISOPYRAMIDE?
- What is Average Wholesale Price for DISOPYRAMIDE?
Summary for DISOPYRAMIDE
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 18 |
| Drug Prices: | Drug price information for DISOPYRAMIDE |
| DailyMed Link: | DISOPYRAMIDE at DailyMed |
US Patents and Regulatory Information for DISOPYRAMIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nesher Pharms | DISOPYRAMIDE PHOSPHATE | disopyramide phosphate | CAPSULE, EXTENDED RELEASE;ORAL | 071200-001 | Dec 15, 1987 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Watson Labs | DISOPYRAMIDE PHOSPHATE | disopyramide phosphate | CAPSULE;ORAL | 070240-001 | Feb 2, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ivax Sub Teva Pharms | DISOPYRAMIDE PHOSPHATE | disopyramide phosphate | CAPSULE;ORAL | 070187-001 | Nov 18, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
